FloSonics Medical seeded with $5 mln in iGan-led round
Sudbury, Ontario-based medical device company FloSonics Medical has raised $5 million in a seed-stage financing. Canadian venture capital firm iGan Partners led the round. It was joined by Genesys Capital, MaRS Investment Accelerator Fund, Accel-RX, MaRS Catalyst, Angel One and Northern Ontario Angels. Founded in 2015, FloSonics is focused on developing non-invasive sensors to improve the management of critically-ill patients. Led by CEO Joe Eibl, the company will use the funds raised to commercialize FloPatch, a wearable sensor which adheres to a patient’s neck and detects blood flow following clinical interventions.
29 January 2018•2 mins read
